RxDoctor Payments Data

Ryan Stephenson, DO

Otolaryngology · Bozeman, MTNPI 1548653850

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,777 of the $2,358 with a category attached, or 75.4%. 18 manufacturers reported payments, led by Stryker at 29.8% of the total. Reporting peaked in 2023 at $1,102 and has fallen 88.7% since, to $125 in 2025.

$2,358in general payments, 2019–2025

Across 42 payments — averaging $56.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$703
  • Inspire Medical Systems, Inc.$470
  • Davol Inc.$290
  • Olympus America Inc.$269
  • Acclarent, Inc$130
  • Itamar Medical Inc$125
  • plus $370 from 12 others

What the payments were for

  • Travel & lodging$58025%
  • Food & beverage$1,77775%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,358 in reported general payments places this provider in the 85th percentile of 34 otolaryngology providers in Montana.

See all otolaryngology providers in Montana

Medicare billing

Part B allowed, 2024
$26,541
Medicare patients
87
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole22$143
Famotidine14$131
Fluticasone Propionate13$114

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Bozeman

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →